• Ema: "Safe and effective AstraZeneca vaccine".

    Draghi: administrations resume in Italy

  • AstraZeneca, the EMA verdict: "Effective vaccine, benefits outweigh the risks"

  • Vaccines.

    British authority: no evidence against AstraZeneca

  • Vaccini, the Public Prosecutor of Catania: "No danger emerges from AstraZeneca"

  • EU: we will send letter to AstraZeneca to resolve the conflict on doses

Share

March 19, 2021

The administration of the AstraZeneca anti-Covid vaccine resumes today throughout Italy, after the green light of the EMA.

At 12 noon, at the headquarters of the Ministry of Health, a press conference will be held which will be attended by the Director General of the Italian Medicines Agency, Nicola Magrini, the Director General for Prevention of the Ministry of Health, Giovanni Rezza, and the President of the Council Superior of Health, Franco Locatelli.

The vaccine of the Anglo-Swedish company had been stopped, as a precaution, after the reporting of some serious adverse cases (thrombo-embolic events).

Subsequent investigations by the EMA have established that there is no link between those events and the vaccine inoculation. 

"The reasons behind the precautionary ban on the use of vaccine batches, issued on March 15, 2021, no longer exist. Therefore, as soon as the Committee for Medicinal Products for Human Use (CHMP) releases its opinion, Aifa will proceed to revoke the ban on the use of the AstraZeneca vaccine, thus allowing a complete resumption of the vaccination campaign starting at 3.00 pm ", Aifa announced yesterday in a statement. 

'I vaccinate me because ... "


First a big message:" I vaccinate me because ... "then the face of a champion. It is the heart of the communication campaign that the Government has in mind. The idea is to involve champions such as Francesco Totti and Valentina Vezzali, but also personalities from the world of culture, cinema, music and information. The newspaper 'La Repubblica' writes it, arguing that the goal is "to fade the anxieties of recent days and cushion the effect disastrous of the temporary suspension of Astrazeneca ". Again according to the newspaper," in the coming days Palazzo Chigi will try to plan the campaign it has in mind.

First of all by gathering the formal support of the big names, all of them with very high 'popularity'.

Then involving the main radio and television newspapers of the country, as well as newspapers and information sites ". The daily adds that Prime Minister Draghi" will announce in the next few hours - perhaps today in a press conference - "his intention to book the ' its' dose ".

Norway and Sweden wait before leaving


Despite Ema declaring the Astrazeneca vaccine "safe and effective", Norway and Sweden consider it premature to resume vaccinations and postpone the decision on the matter for at least a week, in light of the information that will come out from further studies that the EMA is conducting.

"Vaccination with AstraZeneca will remain suspended until we have a complete picture of the situation," the director of the Norwegian Institute of Public Health, Camilla Stoltenberg, told a press conference.

Norway was the first country to report severe thrombo-embolic cases.

Von der Leyen: we will reach the goal of 70% vaccinated by summer


Europe will reach the goal of vaccinating 70% of citizens by the summer.

This was stated by the president of the European Commission Ursula Von der Leyen in

an interview with Repubblica

.

"I am extremely confident that we will achieve the goal, says the president, adding that" we are now focused on doing everything to reduce the spread of the virus by increasing and stabilizing vaccine supplies, we are still in a very worrying situation between variants and third wave. .

I can understand how difficult and frustrating the situation is, how much our citizens suffer but I say that we will judge the crisis when we have overcome it.

I am deeply convinced that we will all understand that the right approach was to be together as a European Union. "

Von der Leyen then announces on the delays of Astrazeneca in the supply of vaccine doses foreseen that "we sent today (yesterday for the reader, ed) a letter of formal notice to AstraZeneca because we want to activate a structured dispute resolution process. there are several open points on contracts and the best way to clarify them is this ".

Finally, on the Russian vaccine, the president of the European Commission states that "Sputnik is now under rolling review, but has not yet requested formal authorization. The second fundamental point - and we see it with AstraZeneca - is that a company must be able to respect supplies and at the moment we have not seen any evidence of Sputnik's production capacity. Before authorizing, the EMA must also certify the production sites and their quality ".

The Ema verdict


"We have come to a conclusion: the AstraZeneca vaccine is effective against coronavirus and the benefits far outweigh the risks, no links have emerged between the vaccine and thromboembolic events. We will do specific studies on the side effects, and we remain confident on vaccines that are fundamental to the challenge we are facing ".

This was stated by Emer Cooke, executive director of the European Medicines Agency (Ema), during a press conference on the review of the Astrazeneca vaccines against Covid-19.

"The conclusion of the EMA review is that it is a safe and effective vaccine."

Emer Cooke said after reviewing AstraZeneca's vaccine-related thrombosis cases.

"We will continue to analyze situations, it is a priority" Thrombosis cases after administration of the AstraZeneca vaccine "are lower" than those occurring among the unvaccinated population.

This was stated by Sabien Straus, president of the Prac (pharmacovigilance commission) at the press conference of the EMA.